The different levels of sensitivity to the IGF-1R inhibitor observed among CCRF-CEM (T-ALL) and NALM6 (Bp-ALL) cells, and within Bp-ALL REH and SupB15 subtypes expressing selected non-random translocations prompted us to investigate the mechanism underlying these differences. Here, IGF1R is linked to acute lymphoblastic leukemia.